European equities traded in the US as American depositary receipts were little changed late Monday morning, easing less than 0.1% to 1,630.2 on the S&P Europe Select ADR Index.

From continental Europe, the risers were led by biotech firm Evaxion (EVAX) and biopharmaceutical company DBV Technologies (DBVT), which gained 5.2% and 4.5% respectively. They were followed by 3D printer company Materialise (MTLS) and biotech firm BioNTech (BNTX), which were up 2.2% and 1.7% respectively.

The decliners from continental Europe were led by consumer goods giant Unilever (UL) and medical device maker EDAP TMS (EDAP), which fell 7.3% and 3.4% respectively. They were followed by pharmaceutical companies Novo Nordisk (NVO) and Sanofi (SNY), which were down 2.9% and 2.1% respectively.

From the UK and Ireland, the gainers were led by biopharmaceutical company Biodexa Pharmaceuticals (BDRX) and biotech firm Autolus Therapeutics (AUTL), which advanced 37% and 3.5% respectively. They were followed by biotech firm Trinity Biotech (TRIB) and biopharmaceutical company Akari Therapeutics (AKTX), which increased 3.1% and 2.8% respectively.

The decliners from the UK and Ireland were led by biopharmaceutical company Amarin (AMRN) and pharmaceutical company Silence Therapeutics (SLN), which dropped 6.2% and 2.2% respectively. They were followed by alcoholic beverage company Diageo (DEO) and mining company BHP Group (BHP), which were off 1.8% and 0.5% respectively.